Atheroprotective immunity and cardiovascular disease: therapeutic opportunities and challenges.
about
The Ratio of Regulatory (FOXP3+) to Total (CD3+) T Cells Determined by Epigenetic Cell Counting and Cardiovascular Disease Risk: A Prospective Case-cohort Study in Non-diabeticsPathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for interventionLinking CD11b (+) Dendritic Cells and Natural Killer T Cells to Plaque Inflammation in Atherosclerosis.Low TLR7 gene expression in atherosclerotic plaques is associated with major adverse cardio- and cerebrovascular events.Atherosclerotic plaque vulnerability in the statin era.Can Circulating Regulatory T Cells Predict Cardiovascular Disease?Assessment of Carrot Callus as Biofactories of an Atherosclerosis Oral Vaccine Prototype.Regulatory T cells as a new therapeutic target for atherosclerosis.
P2860
Q28277713-2CDB680F-F916-48F7-9DAD-39B7B6EEC6E3Q35998510-3DC9531C-8F5D-4466-8E32-1E08D833FFDAQ36718932-0A404901-81DA-47C4-BF4F-8CBA23B7A6FDQ37572208-607DBFD7-5F28-4F0D-85F7-0F84BFD09BD4Q40260623-742A4CDD-8438-456E-B5A9-567CF66DB78DQ42387603-35130EF1-A538-464D-BC90-8333B446AFC9Q47720168-33AFB90F-B8D0-434E-8F05-AAAC729BDD88Q50093330-D8C43779-FC25-4993-9A39-ECF12CC679D8
P2860
Atheroprotective immunity and cardiovascular disease: therapeutic opportunities and challenges.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Atheroprotective immunity and ...... opportunities and challenges.
@en
type
label
Atheroprotective immunity and ...... opportunities and challenges.
@en
prefLabel
Atheroprotective immunity and ...... opportunities and challenges.
@en
P2093
P2860
P356
P1476
Atheroprotective immunity and ...... opportunities and challenges.
@en
P2093
P2860
P304
P356
10.1111/JOIM.12353
P407
P577
2015-02-09T00:00:00Z